Konica Minolta Inc (4902):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Konica Minolta Inc (4902) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7187
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Konica Minolta, Inc. (Konica Minolta) develops, manufactures and sells printing systems and solutions for production print professionals. The company’s product portfolio includes multi-functional peripherals (MFPs), printers, equipment for production print systems and graphic arts, equipment for healthcare systems, measuring instruments for industrial and healthcare applications, inkjet printheads and textile printers for industrial applications. It also develops electronic materials, lighting source panels, functional films and optical products for industrial and commercial purposes. Konica Minolta has manufacturing facilities in the US, France, China, Thailand and Japan. The company operates through consolidated and non-consolidated subsidiaries and affiliates in the Americas, Asia-Pacific, Europe and the Middle East, and Africa. Konica Minolta is headquartered in Tokyo, Japan.

Konica Minolta Inc (4902) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Konica Minolta Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Konica Minolta Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Konica Minolta Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Konica Minolta Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Konica Minolta Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Konica Minolta Inc, Medical Equipment, Deal Details 12
Asset Purchase 12
Konica Minolta Acquires Ultrasonic Diagnostic Equipment Business 12
Venture Financing 13
inviCRO Raises USD45.8 Million in Financing Round 13
Partnerships 14
Heart Imaging Enters into Licensing Agreement with Viztek for Zero Footprint Patent Portfolio 14
Guided Therapeutics Enters Into Licensing Agreement With Konica Minolta 15
Guided Therapeutics Extends Licensing And Co-Development Agreement With Konica Minolta 16
Enigma Biomedical and Invicro to Enter into Co-Development Agreement 17
Enigma Biomedical Enters into Collaboration Agreement with Invicro 18
Fuji Pharma Enters into Agreement with Konica Minolta 19
Bioverativ and Invicro Enter into Agreement 20
Ambry Genetics Partners with Beth Israel Deaconess Medical Center, University of Pittsburgh and HonorHealth Research Institute 21
Konica Minolta, Institut Pasteur and BioAxial Enter into Research Agreement 22
SuperSonic Imagine Enters into Distribution Agreement with Konica Minolta for Aixplorer in Japan 23
Konica Minolta Enters into Distribution Agreement with Inofile for Kno2 24
VuCOMP Enters Into Agreement With Konica Minolta 25
Viztek Enters Into Technology Integration Agreement With Matakina 26
GE Healthcare And Konica Minolta Enter Into Global Distribution Agreement For AeroDR 27
Acquisition 28
inviCRO Acquires CORE Clinical 28
Konica Minolta Acquires Ambry Genetics 29
Konica Minolta Acquires inviCRO 31
inviCRO Acquires Molecular NeuroImaging 32
Konica Minolta Medical Imaging Acquires Viztek 33
Ambry Genetics Acquires Progeny Software 34
Konica Minolta Inc – Key Competitors 35
Konica Minolta Inc – Key Employees 36
Konica Minolta Inc – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 41
Strategy And Business Planning 41
Sep 26, 2018: Konica Minolta launches dedicated Precision Medicine Business in Japan 41
Mar 28, 2017: Konica Minolta and SICK enter a Strategic Alliance in further development of advanced LiDAR-Technology 42
Financial Announcements 43
Aug 01, 2018: Konica Minolta: 1Q / March 2018 consolidated financial results highlight 43
Oct 30, 2017: Konica Minolta: Consolidated Financial Results for the Second Quarter of the Fiscal Year ending March 31, 2018 44
Corporate Communications 45
Jul 26, 2018: Konica Minolta named to all ESG Indexes adopted by the GPIF for two consecutive years and to the FTSE4Good developed Index for 15 consecutive years 45
Mar 15, 2017: Konica Minolta Announces Appointment/Reappointment of Directors and Executive Officers 46
Product News 48
Nov 16, 2017: Konica Minolta’s AeroRemote Insights Provides Interactive Analytic Reporting for Radiology Departments 48
Nov 02, 2017: Konica Minolta Demonstrates Rheumatology Reporting Package for Ultrasound at ACR/ARHP Annual Meeting 49
Jun 13, 2017: Konica Minolta Healthcare Highlights Dynamic Chest Radiography at the World Congress of Thoracic Imaging 50
Feb 17, 2017: A Novel, Quantitative Immunohistochemistry Method Enabled by BioGenex IHC System 51
Other Significant Developments 52
Jun 12, 2018: Akcea and Ambry Genetics to Launch hATTR Compass, a Genetic Testing Program for People with Suspected Hereditary ATTR Amyloidosis 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
Konica Minolta Inc, Medical Equipment, Key Facts, 2018 2
Konica Minolta Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Konica Minolta Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Konica Minolta Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Konica Minolta Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Konica Minolta Inc, Deals By Market, 2012 to YTD 2018 9
Konica Minolta Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Konica Minolta Acquires Ultrasonic Diagnostic Equipment Business 12
inviCRO Raises USD45.8 Million in Financing Round 13
Heart Imaging Enters into Licensing Agreement with Viztek for Zero Footprint Patent Portfolio 14
Guided Therapeutics Enters Into Licensing Agreement With Konica Minolta 15
Guided Therapeutics Extends Licensing And Co-Development Agreement With Konica Minolta 16
Enigma Biomedical and Invicro to Enter into Co-Development Agreement 17
Enigma Biomedical Enters into Collaboration Agreement with Invicro 18
Fuji Pharma Enters into Agreement with Konica Minolta 19
Bioverativ and Invicro Enter into Agreement 20
Ambry Genetics Partners with Beth Israel Deaconess Medical Center, University of Pittsburgh and HonorHealth Research Institute 21
Konica Minolta, Institut Pasteur and BioAxial Enter into Research Agreement 22
SuperSonic Imagine Enters into Distribution Agreement with Konica Minolta for Aixplorer in Japan 23
Konica Minolta Enters into Distribution Agreement with Inofile for Kno2 24
VuCOMP Enters Into Agreement With Konica Minolta 25
Viztek Enters Into Technology Integration Agreement With Matakina 26
GE Healthcare And Konica Minolta Enter Into Global Distribution Agreement For AeroDR 27
inviCRO Acquires CORE Clinical 28
Konica Minolta Acquires Ambry Genetics 29
Konica Minolta Acquires inviCRO 31
inviCRO Acquires Molecular NeuroImaging 32
Konica Minolta Medical Imaging Acquires Viztek 33
Ambry Genetics Acquires Progeny Software 34
Konica Minolta Inc, Key Competitors 35
Konica Minolta Inc, Key Employees 36
Konica Minolta Inc, Other Locations 38
Konica Minolta Inc, Subsidiaries 38

List of Figures
Konica Minolta Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Konica Minolta Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Konica Minolta Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Konica Minolta Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Konica Minolta Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Konica Minolta Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Konica Minolta Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Konica Minolta Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Konica Minolta Inc (4902):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Premier Gold Mines Limited:企業のM&A・事業提携・投資動向
    Premier Gold Mines Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Premier Gold Mines Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • WNDM Medical Inc (WNDM):製薬・医療:M&Aディール及び事業提携情報
    Summary WNDM Medical Inc (WNDM Medical), formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone blee …
  • Printpack Inc:企業の戦略的SWOT分析
    Printpack Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Genesis Energy, L.P.:企業の戦略・SWOT・財務分析
    Genesis Energy, L.P. - Strategy, SWOT and Corporate Finance Report Summary Genesis Energy, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Medicenna Therapeutics Corp (MDNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Medicenna Therapeutics Corp (Medicenna), formerly A2 Acquisition Corp, is a clinical stage immuno-oncology company. The company develops empowered cytokines (EC) and superkines for the treatment of cancer. Its pipeline products include MDNA55, MDNA109, MDNA209, MDNA57, MDNA413, and MDNA132. …
  • Julius Baer:企業のM&A・事業提携・投資動向
    Julius Baer - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Julius Baer Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Bioneer Corp (064550):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioneer Corp (Bioneer) is a molecular diagnostic company that develops and produces molecular research and molecular diagnostic products and instruments. The company’s major molecular research products include DNA/RNA amplification pre mixes, DNA/RNA preparation system, oligo synthesis and r …
  • The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd:企業の戦略的SWOT分析
    The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employee …
  • Quad/Graphics, Inc.:企業の戦略・SWOT・財務情報
    Quad/Graphics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Quad/Graphics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Hogan Lovells International LLP:企業の戦略的SWOT分析
    Hogan Lovells International LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Orca Gold Inc (ORG):企業の財務・戦略的SWOT分析
    Summary Orca Gold Inc (Orca Gold), formerly Canaco Resources Inc, subsidiary of Pinetree Capital Ltd, is a gold exploration company. The company's activities include acquisition, exploration and development of mineral properties in North and West Africa. It holds interests in The Block 14 gold proje …
  • EOG Resources, Inc.:企業の戦略・SWOT・財務情報
    EOG Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary EOG Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Heska Corp (HSKA):企業の財務・戦略的SWOT分析
    Heska Corp (HSKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • LM Wind Power Holding AS:企業の戦略的SWOT分析
    LM Wind Power Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Subex Ltd (SUBEX):企業の財務・戦略的SWOT分析
    Subex Ltd (SUBEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Formosa Laboratories Inc (4746)-製薬・医療分野:企業M&A・提携分析
    Summary Formosa Laboratories Inc (Formosa) is a healthcare products provider that develops ingredients. The company develops and markets active pharmaceutical ingredients and UV filters. Its active pharmaceutical ingredients comprise anticancers, cholesterol and phosphate binders, MRI enhancing agen …
  • TOR Minerals International Inc (TORM):企業の財務・戦略的SWOT分析
    Summary TOR Minerals International Inc (TOR) is a chemical company that manufactures and distributes mineral and pigment products. The company provides products such as optiload, aluprem, haltex, and others. It also offers alumina trihydrate and boehmite halogen-free flame retardant and smoke suppre …
  • Ceapro Inc (CZO)-製薬・医療分野:企業M&A・提携分析
    Summary Ceapro Inc (Ceapro) is a biotechnology company which focuses on the development of extraction technology for use in the production of extracts and active ingredients from oats and other renewable plant resources. These extracts find application in therapeutic products for both humans and ani …
  • Shin Poong PharmCo Ltd (019170):製薬・医療:M&Aディール及び事業提携情報
    Summary Shin Poong PharmCo Ltd (Shin Poong) is a contract manufacturing company that manufactures and markets pharmaceutical products and active pharmaceutical ingredients. The company provides drugs such as psychoneurotic, anti-cancer, cardiovascular, antihistamine, antirheumatic and benign prostat …
  • Zecotek Photonics Inc (ZMS):企業の財務・戦略的SWOT分析
    Zecotek Photonics Inc (ZMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆